Search Browse Earnings

Karuna Therapeutics, Inc. — SlamSEC

Karuna Therapeutics, Inc.

Pharmaceutical Preparations·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$37.0M

FY 2023

Adj. EBITDA

-$143.3M

-387.8% margin

FY 2023

Net Income

-$143.8M

-389.0% margin

FY 2023

EPS (Diluted)

-$4.94

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$248.3M

FY 2023

Total Debt

—

Net Cash

$248.3M

FY 2023

Enterprise Value

—

Debt / EBITDA

1.7x

FY 2023

EV / EBITDA

—

Employees

—